Global and United States Cytomegalovirus Disease Treatments Market Report & Forecast 2023-2028

Report ID: 1825591 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cytomegalovirus Disease Treatments Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cytomegalovirus Disease Treatments Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cytomegalovirus Disease Treatments Market Size for the Year 2017-2028
        1.2.2 Global Cytomegalovirus Disease Treatments Market Size for the Year 2017-2028
    1.3 Cytomegalovirus Disease Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cytomegalovirus Disease Treatments in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cytomegalovirus Disease Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cytomegalovirus Disease Treatments Market Dynamics
        1.4.1 Cytomegalovirus Disease Treatments Industry Trends
        1.4.2 Cytomegalovirus Disease Treatments Market Drivers
        1.4.3 Cytomegalovirus Disease Treatments Market Challenges
        1.4.4 Cytomegalovirus Disease Treatments Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cytomegalovirus Disease Treatments by Type
    2.1 Cytomegalovirus Disease Treatments Market Segment by Type
        2.1.1 Ganciclovir
        2.1.2 Valganciclovir
        2.1.3 Foscarnet
        2.1.4 Cidofovir
        2.1.5 Others
    2.2 Global Cytomegalovirus Disease Treatments Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cytomegalovirus Disease Treatments Market Size by Type (2017-2028)
    2.4 United States Cytomegalovirus Disease Treatments Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cytomegalovirus Disease Treatments Market Size by Type (2017-2028)
3 Cytomegalovirus Disease Treatments by Application
    3.1 Cytomegalovirus Disease Treatments Market Segment by Application
        3.1.1 Stem Cell Transplantation
        3.1.2 Organ Transplantation
        3.1.3 Congenital CMV Infection
        3.1.4 Others
    3.2 Global Cytomegalovirus Disease Treatments Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cytomegalovirus Disease Treatments Market Size by Application (2017-2028)
    3.4 United States Cytomegalovirus Disease Treatments Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cytomegalovirus Disease Treatments Market Size by Application (2017-2028)
4 Global Cytomegalovirus Disease Treatments Competitor Landscape by Company
    4.1 Global Cytomegalovirus Disease Treatments Market Size by Company
        4.1.1 Top Global Cytomegalovirus Disease Treatments Companies Ranked by Revenue (2021)
        4.1.2 Global Cytomegalovirus Disease Treatments Revenue by Player (2017-2022)
    4.2 Global Cytomegalovirus Disease Treatments Concentration Ratio (CR)
        4.2.1 Cytomegalovirus Disease Treatments Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cytomegalovirus Disease Treatments in 2021
        4.2.3 Global Cytomegalovirus Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cytomegalovirus Disease Treatments Headquarters, Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cytomegalovirus Disease Treatments Headquarters and Area Served
        4.3.2 Global Cytomegalovirus Disease Treatments Companies Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cytomegalovirus Disease Treatments Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cytomegalovirus Disease Treatments Market Size by Company
        4.5.1 Top Cytomegalovirus Disease Treatments Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cytomegalovirus Disease Treatments Revenue by Players (2020, 2021 & 2022)
5 Global Cytomegalovirus Disease Treatments Market Size by Region
    5.1 Global Cytomegalovirus Disease Treatments Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cytomegalovirus Disease Treatments Market Size by Region (2017-2028)
        5.2.1 Global Cytomegalovirus Disease Treatments Market Size by Region: 2017-2022
        5.2.2 Global Cytomegalovirus Disease Treatments Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cytomegalovirus Disease Treatments Market Size YoY Growth 2017-2028
        6.1.2 North America Cytomegalovirus Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cytomegalovirus Disease Treatments Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cytomegalovirus Disease Treatments Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cytomegalovirus Disease Treatments Market Size YoY Growth 2017-2028
        6.3.2 Europe Cytomegalovirus Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cytomegalovirus Disease Treatments Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cytomegalovirus Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cytomegalovirus Disease Treatments Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cytomegalovirus Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Merck
        7.1.1 Merck Company Details
        7.1.2 Merck Business Overview
        7.1.3 Merck Cytomegalovirus Disease Treatments Introduction
        7.1.4 Merck Revenue in Cytomegalovirus Disease Treatments Business (2017-2022)
        7.1.5 Merck Recent Development
    7.2 Chimerix
        7.2.1 Chimerix Company Details
        7.2.2 Chimerix Business Overview
        7.2.3 Chimerix Cytomegalovirus Disease Treatments Introduction
        7.2.4 Chimerix Revenue in Cytomegalovirus Disease Treatments Business (2017-2022)
        7.2.5 Chimerix Recent Development
    7.3 Abbott
        7.3.1 Abbott Company Details
        7.3.2 Abbott Business Overview
        7.3.3 Abbott Cytomegalovirus Disease Treatments Introduction
        7.3.4 Abbott Revenue in Cytomegalovirus Disease Treatments Business (2017-2022)
        7.3.5 Abbott Recent Development
    7.4 Bio-Rad
        7.4.1 Bio-Rad Company Details
        7.4.2 Bio-Rad Business Overview
        7.4.3 Bio-Rad Cytomegalovirus Disease Treatments Introduction
        7.4.4 Bio-Rad Revenue in Cytomegalovirus Disease Treatments Business (2017-2022)
        7.4.5 Bio-Rad Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche Cytomegalovirus Disease Treatments Introduction
        7.5.4 Roche Revenue in Cytomegalovirus Disease Treatments Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 Gilead Sciences
        7.6.1 Gilead Sciences Company Details
        7.6.2 Gilead Sciences Business Overview
        7.6.3 Gilead Sciences Cytomegalovirus Disease Treatments Introduction
        7.6.4 Gilead Sciences Revenue in Cytomegalovirus Disease Treatments Business (2017-2022)
        7.6.5 Gilead Sciences Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cytomegalovirus Disease Treatments Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cytomegalovirus Disease Treatments Market Trends
    Table 3. Cytomegalovirus Disease Treatments Market Drivers
    Table 4. Cytomegalovirus Disease Treatments Market Challenges
    Table 5. Cytomegalovirus Disease Treatments Market Restraints
    Table 6. Global Cytomegalovirus Disease Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cytomegalovirus Disease Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cytomegalovirus Disease Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cytomegalovirus Disease Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cytomegalovirus Disease Treatments Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cytomegalovirus Disease Treatments Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cytomegalovirus Disease Treatments Revenue Share by Player, 2017-2022
    Table 13. Global Cytomegalovirus Disease Treatments Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cytomegalovirus Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Disease Treatments as of 2021)
    Table 15. Top Players of Cytomegalovirus Disease Treatments in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cytomegalovirus Disease Treatments Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cytomegalovirus Disease Treatments Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cytomegalovirus Disease Treatments Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cytomegalovirus Disease Treatments Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cytomegalovirus Disease Treatments Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cytomegalovirus Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cytomegalovirus Disease Treatments Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cytomegalovirus Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cytomegalovirus Disease Treatments Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cytomegalovirus Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cytomegalovirus Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cytomegalovirus Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Merck Company Details
    Table 31. Merck Business Overview
    Table 32. Merck Cytomegalovirus Disease Treatments Product
    Table 33. Merck Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million)
    Table 34. Merck Recent Development
    Table 35. Chimerix Company Details
    Table 36. Chimerix Business Overview
    Table 37. Chimerix Cytomegalovirus Disease Treatments Product
    Table 38. Chimerix Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million)
    Table 39. Chimerix Recent Development
    Table 40. Abbott Company Details
    Table 41. Abbott Business Overview
    Table 42. Abbott Cytomegalovirus Disease Treatments Product
    Table 43. Abbott Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million)
    Table 44. Abbott Recent Development
    Table 45. Bio-Rad Company Details
    Table 46. Bio-Rad Business Overview
    Table 47. Bio-Rad Cytomegalovirus Disease Treatments Product
    Table 48. Bio-Rad Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million)
    Table 49. Bio-Rad Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Cytomegalovirus Disease Treatments Product
    Table 53. Roche Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Gilead Sciences Company Details
    Table 56. Gilead Sciences Business Overview
    Table 57. Gilead Sciences Cytomegalovirus Disease Treatments Product
    Table 58. Gilead Sciences Revenue in Cytomegalovirus Disease Treatments Business (2017-2022) & (US$ Million)
    Table 59. Gilead Sciences Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cytomegalovirus Disease Treatments Product Picture
    Figure 2. Global Cytomegalovirus Disease Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cytomegalovirus Disease Treatments Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cytomegalovirus Disease Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cytomegalovirus Disease Treatments Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cytomegalovirus Disease Treatments Market Share in Global 2017-2028
    Figure 7. Cytomegalovirus Disease Treatments Report Years Considered
    Figure 8. Product Picture of Ganciclovir
    Figure 9. Product Picture of Valganciclovir
    Figure 10. Product Picture of Foscarnet
    Figure 11. Product Picture of Cidofovir
    Figure 12. Product Picture of Others
    Figure 13. Global Cytomegalovirus Disease Treatments Market Share by Type in 2022 & 2028
    Figure 14. Global Cytomegalovirus Disease Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Cytomegalovirus Disease Treatments Market Share by Type (2017-2028)
    Figure 16. United States Cytomegalovirus Disease Treatments Market Share by Type in 2022 & 2028
    Figure 17. United States Cytomegalovirus Disease Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Cytomegalovirus Disease Treatments Market Share by Type (2017-2028)
    Figure 19. Product Picture of Stem Cell Transplantation
    Figure 20. Product Picture of Organ Transplantation
    Figure 21. Product Picture of Congenital CMV Infection
    Figure 22. Product Picture of Others
    Figure 23. Global Cytomegalovirus Disease Treatments Market Share by Application in 2022 & 2028
    Figure 24. Global Cytomegalovirus Disease Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Cytomegalovirus Disease Treatments Market Share by Application (2017-2028)
    Figure 26. United States Cytomegalovirus Disease Treatments Market Share by Application in 2022 & 2028
    Figure 27. United States Cytomegalovirus Disease Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Cytomegalovirus Disease Treatments Market Share by Application (2017-2028)
    Figure 29. North America Cytomegalovirus Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Cytomegalovirus Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Cytomegalovirus Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Cytomegalovirus Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Cytomegalovirus Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Cytomegalovirus Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Merck Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2017-2022)
    Figure 58. Chimerix Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2017-2022)
    Figure 59. Abbott Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2017-2022)
    Figure 60. Bio-Rad Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2017-2022)
    Figure 61. Roche Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2017-2022)
    Figure 62. Gilead Sciences Revenue Growth Rate in Cytomegalovirus Disease Treatments Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Chimerix
Abbott
Bio-Rad
Roche
Gilead Sciences
Frequently Asked Questions
Cytomegalovirus Disease Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cytomegalovirus Disease Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cytomegalovirus Disease Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports